Research brief
Huntington’s disease (HD) is a devastating neurodegenerative disorder characterised by motor, cognitive, and psychiatric symptoms. Despite being linked to a CAG repeat expansion in the HTT gene, the precise mechanisms driving its pathology remain elusive. A recent study published in Nature Neuroscience by Dr. Leslie M. Thompson and her team at the University of California, Irvine, provides significant insights into the molecular underpinnings of HD. The research focuses on aberrant RNA splicing, alterations in RNA modifications, and disruptions in the critical RNA-binding protein TDP-43.
TDP-43 and RNA Splicing in HD
TDP-43, a protein well-known for its role in RNA splicing, was found to mislocalise in HD mouse and human brains, accumulating in cytoplasmic aggregates and losing its normal nuclear function. This mislocalisation disrupts RNA splicing, particularly in genes associated with synaptic function and neuronal development. Notably, the study identified widespread exon skipping in both HD mouse models and human brain tissues, suggesting a conserved and significant splicing signature in HD.
“TDP-43 dysfunction has long been implicated in other neurodegenerative diseases, but our findings reveal its critical role in Huntington’s,” explains Dr. Thompson. “This mislocalization likely contributes to the widespread RNA splicing abnormalities observed in the disease.”
The Role of m6A RNA Modification
In addition to TDP-43, the study explored the role of N6-methyladenosine (m6A), a chemical modification on RNA that regulates its stability, localisation, and translation. In HD, the researchers observed a decrease in m6A modifications on RNAs linked to genes affected by TDP-43 dysfunction. These changes further disrupt RNA processing, compounding the molecular dysfunctions in HD.
Implications for Therapeutic Development
These findings highlight new potential therapeutic targets. Interventions to restore TDP-43 nuclear localisation or correct m6A modifications could mitigate the downstream effects of RNA misprocessing in HD. What’s more, understanding how these molecular events interact offers hope for broader applications in neurodegenerative disease treatment.
The study underscores the complexity of HD pathology, emphasising the interconnected roles of RNA modifications and protein dysregulation. As research advances, these insights may pave the way for novel therapeutic strategies to combat HD and other related disorders.
Discover more from Neurospan
Subscribe to get the latest posts sent to your email.
